Vita Plus 500 Pwr 1.6 g Powder is a Health Canada–registered veterinary drug (DIN 01912909) held by Jaapharm Canada Inc., containing Cupric Sulfate. Health Canada lists its status as Cancelled Post Market (status date 10 Aug 2016). Nexara Health has matched 13 registrations of Cupric Sulfate across 2 other regulated markets.
Health Canada registration
| DIN | 01912909 |
|---|---|
| Brand name | Vita Plus 500 Pwr |
| Active ingredient | Cupric Sulfate |
| Strength | 1.6 g |
| Dosage form | Powder |
| Route | Oral |
| Company | Jaapharm Canada Inc. |
| Status | Cancelled Post Market — 10 Aug 2016 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Cupric Sulfate registered in other markets
13 registrations of the same molecule in 2 national registries outside Canada (first 9 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Taiwan | Cupric Sulfate Anhydrous Powder | Eli. Lilly & Co. | （粉） | 已註銷 | TFDA | |
| United States | Copper | Hospira, Inc. | Injection, Solution | listed | FDA NDC | |
| United States | Cupric Chloride | Somerset Therapeutics, LLC | Injection | listed | FDA NDC | |
| United States | Cupric Chloride | Renova Pharmaceuticals LLC | Injection, Solution | listed | FDA NDC | |
| United States | Cupric Chloride | Metrochem API Private Limited | Powder | FDA NDC | ||
| United States | Cupric Chloride | Exela Pharma Sciences, LLC | Injection, Solution | listed | FDA NDC | |
| United States | Cupric Chloride | Northstar Rx LLC | Injection, Solution | listed | FDA NDC | |
| United States | Cupric Chloride | Archis Pharma LLC | Injection, Solution | listed | FDA NDC | |
| United States | Cupric Chloride | Amneal Pharmaceuticals Private Limited | Injection, Solution | listed | FDA NDC |
See every manufacturer of Cupric Sulfate worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Vita Plus 500 Pwr (DIN 01912909) marketed in Canada?
No. Health Canada lists DIN 01912909 as Cancelled Post Market as of 10 Aug 2016.
Who holds the Canadian licence for this product?
Jaapharm Canada Inc. is the company of record in the Health Canada Drug Product Database.
Is Cupric Sulfate registered outside Canada?
Yes — Nexara Health has matched 13 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 01912909, status date 2016-08-10; national medicine registries: FDA NDC, TFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 01912909, status date 2016-08-10; national medicine registries: FDA NDC, TFDA.
Health Canada Drug Product Database (DPD), DIN 01912909, status date 2016-08-10; national medicine registries: FDA NDC, TFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.